help us beat brain cancer

Ependymoma is the third most common pediatric central nervous system (CNS) tumor, accounting for 8-10% of all diagnoses, and occurring most frequently in the posterior fossa. Unfortunately, outcomes for ependymomas are suboptimal - overall survival is 50-64%.

The treatments for ependymoma have not changed in any significant way for decades, which is why we need a new approach.

Please help us support new research to save the lives of children diagnosed with this challenging disease.